Haplo-identical Viral-Specific T-cells(St. Jude Children's Research Hospital)

N/A

Report date: 2024/04/02 20:00:40

Base Information

Drug NameHaplo-identical Viral-Specific T-cells(St. Jude Children's Research Hospital)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Donor > AllogeneicCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Virus-specific T Cell therapyCell and gene therapy > Cell therapy > Source of cells > Peripheral blood-derived

Mechanisms of ActionImmunologic cytotoxicityT lymphocyte replacements

TargetsNot applicable

Therapy Area/IndicationsCytomegalovirus Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesSt. Jude Children'S Research Hospital

China Registration ClassN/A

Develop Information

Active CompaniesSt. Jude Children'S Research Hospital

Inactive CompaniesN/A

Active IndicationsCytomegalovirus Infections

Inactive IndicationsN/A

Other Information

ATC CodeN/A